Harmony Biosciences Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 25, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | |
|---|---|---|---|
| | HARMONY BIOSCIENCES HOLDINGS, INC. | ||
| | | | |
| | By: | /s/ Jeffrey M. Dayno | |
| | Name: | Jeffrey M. Dayno | |
| | Title: | | |
| | | President, Chief Executive Officer and Director (principal executive officer) | |
**Date:**February 25, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | | Title | | Date |
|---|---|---|---|---|
| | | | | |
| /s/ Jeffrey M. Dayno | | President, Chief Executive Officer and Director | | February 25, 2025 |
| Jeffrey M. Dayno | | (Principal Executive Officer) | | |
| | | | | |
| /s/ Sandip Kapadia | | Chief Financial Officer and Chief Administrative Officer (Principal | | February 25, 2025 |
| Sandip Kapadia | | Financial Officer and Principal Accounting Officer) | | |
| | | | | |
| /s/ Jeffrey S. Aronin | | Chairman of the Board | | February 25, 2025 |
| Jeffrey S. Aronin | | | | |
| | | | | |
| /s/ Peter Anastasiou | | Director | | February 25, 2025 |
| Peter Anastasiou | | | | |
| | | | | |
| /s/ Antonio Gracias | | Director | | February 25, 2025 |
| Antonio Gracias | | | | |
| | | | | |
| /s/ R. Mark Graf | | Director | | February 25, 2025 |
| R. Mark Graf | | | | |
| | | | | |
| /s/ Juan A. Sabater | | Director | | February 25, 2025 |
| Juan A. Sabater | | | | |
| | | | | |
| /s/ Gary Sender | | Director | | February 25, 2025 |
| Gary Sender | | | | |
| | | | | |
| /s/ Linda Szyper | | Director | | February 25, 2025 |
| Linda Szyper | | | | |
| | | | | |
| /s/ Andreas Wicki | | Director | | February 25, 2025 |
| Andreas Wicki | | | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.